Delivery Order SPE2DB22D3301-SPE2DB25FZ0WS
- Not listed
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $14,887.74 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prolia 60 mg/ml syringes. This non-set-aside, firm fixed price contract is scheduled for completion by August 20, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $19,857.04 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with a firm fixed price contract type and ultimate completion date of August 8, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a $12,726.40 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, with an ultimate completion date of July 28, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $67,829.29 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $26,999.75 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Prolia 60 mg/ml syringes. This firm fixed price contract is non-competitive with no set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,459.35 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price terms and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $36,928.09 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, non-set-aside contract executed on July 26, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $19,310.96 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. AmerisourceBergen will perform the work from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical supplier within the federal medical procurement...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0WSDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,350.56 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract represents a call against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company maintains a substantial portfolio of federal contracts covering specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This delivery order for Prolia, a bone health medication, reflects the company's ongoing role as a primary vendor for Defense Logistics Agency medical supply chain operations, demonstrating its capability to fulfill federal procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 9/12/25 |